Patients with Parkinson's Disease face a wide range of challenges that can extend to their caregivers. One newly studied area in this field is psychosis for this patient population and what can be done to help them.
In the early stages of treatment for Parkinson's Disease Levodopa is a popular option for patients. As the effects of the medication wear off it can make life difficult for these patients as they wait for their next dose. A new inhaled formulation could help fill in the gaps for this patient population.
Half of very young children with ADHD are treated with medication rather than the behavioral modification that the American Academy of Pediatrics has recommended as first-line treatment, a CDC report finds.
Yutao Liu, MD, PhD, Georgia Regents University, discussed how he and his team can potentially target genes to either reduce glaucoma or provide neuroprotection specifically for the mitochondria in the retina.
Looking to become the latest addition to the field of treatment options for multiple sclerosis Zinbryta continues to show positive results during clinical trials as it awaits the final steps of the regulatory approval process in the United States and elsewhere.
According to Henry Kaplan, MD, University of Louisville School of Medicine, "One has to recognize that there are multiple approaches like gene therapy, neuroprotection, stem cell transplantation, and pharmacologic manipulation of other genes really holds the greatest benefit in terms of trying to reverse the inevitable loss of vision."
Henry Kaplan, MD, KY Lions Eye Center, University of Louisville School of Medicine, is focusing his efforts on figuring out how to preserve or recover lost central vision in patients with retinitis pigmentosa.
Previous research has red-flagged migraines as being associated with silent brain infarcts and white matter hyperintensities (WMH). However, a team of doctors in Denmark found zero evidence to back that up.